Back
New Look on Ureterocolic Diversion with Adjuvant Radiotherapy; SECI (South Egypt Cancer Institute) Experience
Badawy M. Ahmed, Ebrahim Aboeleuon, Ahmed M. Abdel-Rahim, Osama M. Abd Elbadee
J. Cancer Ther. Vol.9 No.11, November 20, 2018  DOI: 10.4236/jct.2018.911074
       (PDF  320K)     HTML      XML
Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom
Amany M. Ali, Amira M. Mohamed, Shimaa Ahmed, Mohamed Abdallah, Tarek M. Alsaba, Samar Mansour
J. Cancer Ther. Vol.9 No.7, July 10, 2018  DOI: 10.4236/jct.2018.97046
       (PDF  523K)     HTML      XML
Feasibility of Concurrent Radiotherapy and Paclitaxel-Based Chemotherapy after Conservative Surgery for Breast Cancer
Hamza Abbas, Alia M. Attia, Ahmed A. S. Salem, Gamal Amira, Adel Gabr, Reham El Morshedy, Mohamed Hamdy
J. Cancer Ther. Vol.8 No.11, November 30, 2017  DOI: 10.4236/jct.2017.811091
       (PDF  507K)     HTML      XML
Toxicity of Hypofractionated Radiotherapy Following Breast Conservative Surgery in Breast Cancer
Aiat Morsy, Sara H. Hammouda, Samir Shehata, Ali Zedan
J. Cancer Ther. Vol.10 No.5, May 23, 2019  DOI: 10.4236/jct.2019.105031
       (PDF  898K)     HTML      XML
Excision Repair Cross-Complementation Group 1 (ERCC1): A Prognostic and Predictive Biomarker in Patients with Colorectal Cancer Receiving Adjuvant Oxaliplatin Based Chemotherapy
Adel Gabr, T. M. Elsaba, Khalid Razek, Shaima Tamam, Haisam Atta
J. Cancer Ther. Vol.7 No.9, September 01, 2016  DOI: 10.4236/jct.2016.79065
       (PDF  4064K)     HTML      XML
 
 
Top